Korean J Med.
2010 Nov;79(5):587-591.
A case of successful posaconazole salvage therapy for rhinocerebral mucormycosis after failure of amphotericin B
- Affiliations
-
- 1Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea. hyucklee@gmail.com
- 2Department of Opthalmology, Dong-A University College of Medicine, Busan, Korea.
- 3Department of Pathology, Dong-A University College of Medicine, Busan, Korea.
Abstract
- A 58-year-old man with uncontrolled type 2 diabetes mellitus developed rhinocerebral mucormycosis. The infection progressed to intracranial extension despite more than 5 weeks of treatment with amphotericin B. The patient then received oral posaconazole, 800 mg/d, in divided doses for 6 months. Salvage treatment with the new azole antifungal posaconazole resulted in dramatic clinical improvement as early as 1 week after the initiation of therapy. Oral posaconazole continued through 24 weeks of treatment, with marked clinical, mycological, and radiological improvements and no adverse events. Here we review the medical literature on rhinocerebral mucormycosis, which is a rapidly progressive and often fatal infection. The treatment of choice is amphotericin B, which failed in our patient. Our case report suggests that posaconazole appears to be a well tolerated and effective salvage treatment option for rhinocerebral mucormycosis, including disseminated disease.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Rhino-Orbital-Cerebral Mucormycosis Successfully Treated by Surgical Treatment and Posaconazole
- Successful Treatment of Rhino-Orbital Mucormycosis with Posaconazole after Combination of Surgical Treatment and Amphotericin B
- Two Cases of Rhinocerebral Mucormycosis in Diabetic Patients
- Pulmonary Mucormycosis Treated Successfully with Posaconazole as Salvage Therapy
- A Case of Cutaneous Mucormycosis
